Aygestin is a synthetic progestin derivative of 19-norprogesterone used clinically in various therapeutic contexts. Its primary therapeutic role is to induce controlled hormonal withdrawal that supports the endometrial lining for assisted reproductive procedures. The drug exerts its pharmacodynamic effects by binding to the progesterone receptor with high affinity and activating anti-estrogenic signaling pathways. Activation of the progesterone receptor modulates transcription of genes involved in uterine decidualization and stabilizes the secretory phase. Pharmacokinetically Aygestin is metabolized in the liver by cytochrome enzymes to inactive metabolites that are cleared renally. This combined receptor interaction and hepatic metabolism profile enables predictable dosing regimens for clinical applications.

Aygestin is a synthetic progestin used primarily in hormonal contraception and hormone replacement therapy. It works by binding to progesterone receptors in the uterus and other target tissues. This binding alters the expression of genes that regulate endometrial lining growth and secretory transformation. By maintaining a hormonally inactive endometrial environment the medication prevents implantation of a fertilized egg. Additionally Aygestin suppresses the midcycle luteinizing hormone surge which reduces ovulation in some formulations. The drug also causes thickening of cervical mucus limiting sperm penetration and survival. These combined actions produce a reliable contraceptive effect while minimizing breakthrough bleeding compared to some older progestins. The pharmacodynamic effect of Aygestin derives from its high affinity for the progesterone receptor and its resistance to rapid metabolic breakdown.

Aygestin may cause nausea in some users. Headache or dizziness can occur. Weight changes such as gain or loss are reported. Breast tenderness or enlargement may happen. Irregular spotting or breakthrough bleeding can appear. Mood disturbances like irritability or depression are possible. In rare cases it may increase the risk of blood clots.

Aygestin may cause irregular menstrual bleeding in some users. Weight changes such as gain or loss have been reported. Some people experience headaches or dizziness. Breast tenderness or enlargement can occur. Nausea or mild stomach discomfort is occasionally noted. Mood alterations including irritability have been documented. Skin reactions such as acne or rash may appear. In rare cases, changes in sexual desire have been observed.